Another study that assessed the relationship between the CNV fraction and response to anti-PD-(L)1 in 248 non-small cell lung cancer (NSCLC) patients showed an inverse relation between the CNV fraction and response to checkpoint inhibitors (p = 0.02) [39]. The gene discussed is CD274; the disease is non-small cell lung carcinoma.